"At UM Center of Diabetes and Endocrinology at Midtown, our endocrinologists diagnose and treat conditions related to hormones, including diabetes."

During the past decade, University of Maryland Joslin Diabetes Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "University of Maryland Joslin Diabetes Center" are "Diabetes Mellitus, Non-Insulin-Dependent" (1 trials) and "Diabetes Mellitus, Type 1" (1 trials). Many other conditions were trialed in "University of Maryland Joslin Diabetes Center" in a lesser frequency.

Most popular intervention types in "University of Maryland Joslin Diabetes Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "AC2993" (1 trials) and "Pramlintide acetate" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Maryland Joslin Diabetes Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "University of Maryland Joslin Diabetes Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in University of Maryland Joslin Diabetes Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Maryland Joslin Diabetes Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".